Ishiguro; Takahiro
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ishiguro; Takahiro.The latest application filed is for "cytotoxicity-inducing therapeutic agent".
- Ishiguro; Takahiro - Kanagawa JP
- ISHIGURO; Takahiro - Tokyo JP
- ISHIGURO; Takahiro - Chiryu-shi JP
- Ishiguro; Takahiro - Kawagawa JP
| Patent | Date |
|---|---|
| Cytotoxicity-inducing Therapeutic Agent App 20220041756 - Nezu; Junichi ; et al. | 2022-02-10 |
| Cell Injury Inducing Therapeutic Drug For Use In Cancer Therapy App 20210388110 - KINOSHITA; Yasuko ; et al. | 2021-12-16 |
| Cytotoxicity-inducing Therapeutic Agent App 20210230311 - NEZU; Junichi ; et al. | 2021-07-29 |
| Cell injury inducing therapeutic drug for use in cancer therapy Grant 11,072,666 - Kinoshita , et al. July 27, 2 | 2021-07-27 |
| Cytotoxicity-inducing therapeutic agent Grant 11,066,483 - Nezu , et al. July 20, 2 | 2021-07-20 |
| Cytotoxicity-inducing therapeutic agent Grant 11,001,643 - Nezu , et al. May 11, 2 | 2021-05-11 |
| Gene-modified Non-human Animal Expressing Human Gpc3 Polypeptide App 20200229408 - JISHAGE; Koichi ; et al. | 2020-07-23 |
| Method For Predicting Martensitic Transformation Rate And Method For Setting Processing Condition App 20200224289 - YANAGIMOTO; Jun ; et al. | 2020-07-16 |
| Cytotoxicity-inducing Therapeutic Agent App 20200123256 - Hoshino; Mayumi ; et al. | 2020-04-23 |
| Cell Injury Inducing Therapeutic Drug For Use In Cancer Therapy App 20200048361 - KINOSHITA; Yasuko ; et al. | 2020-02-13 |
| Gene-modified Non-human Animal Expressing Human Gpc3 Polypeptide App 20190174731 - JISHAGE; Koichi ; et al. | 2019-06-13 |
| Cytotoxicity-inducing Therapeutic Agent App 20180244805 - NEZU; Junichi ; et al. | 2018-08-30 |
| Non-human Animal Having Human Cd3 Gene Substituted For Endogenous Cd3 Gene App 20180192623 - JISHAGE; Koichi ; et al. | 2018-07-12 |
| Cytotoxicity-inducing theraputic agent Grant 9,975,966 - Nezu , et al. May 22, 2 | 2018-05-22 |
| Cytotoxicity-Inducing Therapeutic Agent App 20170267783 - NEZU; Junichi ; et al. | 2017-09-21 |
| T Cell-Redirected Antigen-Binding Molecule For Cells Having Immunosuppression Function App 20170260271 - IGAWA; Tomoyuki ; et al. | 2017-09-14 |
| Anti-Glypican-3 Antibody Having Improved Kinetics in Plasma App 20150315278 - IGAWA; Tomoyuki ; et al. | 2015-11-05 |
| Anti-Glypican 3 Antibody App 20150259417 - Nakano; Kiyotaka ; et al. | 2015-09-17 |
| Cytotoxicity-inducing Therapeutic Agent App 20140112914 - Nezu; Junichi ; et al. | 2014-04-24 |
| Anti-glypican-3 Antibody Having Improved Kinetics In Plasma App 20130295612 - IGAWA; Tomoyuki ; et al. | 2013-11-07 |
| Anti-glypican-3 antibody having improved kinetics in plasma Grant 8,497,355 - Igawa , et al. July 30, 2 | 2013-07-30 |
| Liver Cancer Drug App 20110104157 - Kinoshita; Yasuko ; et al. | 2011-05-05 |
| Anti-glypican 3 antibody Grant 7,919,086 - Nakano , et al. April 5, 2 | 2011-04-05 |
| Anti-Glypican 3 Antibody Having Modified Sugar Chain App 20110033452 - Nakano; Kiyotaka ; et al. | 2011-02-10 |
| Anti-glypican 3 antibody having modified sugar chain Grant 7,867,734 - Nakano , et al. January 11, 2 | 2011-01-11 |
| Anti-Glypican 3 Antibody App 20100248359 - Nakano; Kiyotaka ; et al. | 2010-09-30 |
| Anti-glypican-3 Antibody Having Improved Kinetics In Plasma App 20100239577 - Igawa; Tomoyuki ; et al. | 2010-09-23 |
| Anti-Glypican 3 Antibody Having Modified Sugar Chain App 20080124330 - Nakano; Kiyotaka ; et al. | 2008-05-29 |
| Anti-glypican 3 antibody App 20070190599 - Nakano; Kiyotaka ; et al. | 2007-08-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 